O

Opthea Limited
D

OPT

3.27000
USD
0.13
(4.14%)
مغلق
حجم التداول
9,601
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
503,209,924
الأخبار

العنوان: Opthea Limited

القطاع: Healthcare
الصناعة: Biotechnology
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.